Danaher Corporation (DHR)
Market Cap | 168.18B |
Revenue (ttm) | 18.36B |
Net Income (ttm) | 3.57B |
Shares Out | 710.90M |
EPS (ttm) | 4.96 |
PE Ratio | 47.73 |
Forward PE | 34.84 |
Dividend | $0.72 |
Dividend Yield | 0.30% |
Trading Day | January 15 |
Last Price | $236.75 |
Previous Close | $236.70 |
Change ($) | 0.05 |
Change (%) | 0.02% |
Day's Open | 236.70 |
Day's Range | 234.94 - 238.98 |
Day's Volume | 2,041,836 |
52-Week Range | 120.89 - 245.26 |
The Danaher Corporation uses a continuous improvement strategy called the Danaher Business System. After starting as a Lean Manufacturing practice, it evolved and expanded into a system that a...
Danaher Corporation (DHR) CEO Rainer Blair Presents at J.P. Morgan Healthcare Conference Call Transcript
WASHINGTON, Jan. 13, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment today on the C...
We have narrowed down our search to seven corporate behemoths that have strong growth potential in 2021. These are: TSLA, SQ, NVDA, FB, AVGO, DHR and QCOM.
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
WASHINGTON, Jan. 7, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare...
WASHINGTON, Jan. 7, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2020 on Thursday, January ...
We have selected eight stocks that have strong strong potential for 2021 and beyond. These are: DE, MU, GM, TSLA, FDX, NVDA, DHR and GOOGL.
Water doesn't typically get the same focus that I put on other utilities like electric and gas companies. Though, that doesn't mean that investing in water ETFs doesn't have its own merits; it...
WASHINGTON, Dec. 21, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that Jose-Carlos ("JC") Gutierrez-Ramos has been named Senior Vice President and Chief Scientific Offi...
We have narrowed down our search to five corporate behemoths that have popped more than 30% year to date. These are: NVDA, DHR, UPS, MSFT and AVGO.
Three well-run companies and what investors can take away from their outperformance in the past decade.
Danaher Corporation (DHR) CEO Rainer Blair Presents at Evercore ISI 3rd Annual HealthCONx Brokers Conference (Transcript)
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. So insider b...
Science and technology company Danaher Corporation (NYSE: DHR) boasts a high-quality and defensive portfolio that has become "less compelling to own" ahead of a cyclical recovery into 2021, ac...
It will be prudent to invest in large-cap stocks with a favorable Zacks Rank that are members of any of the three large-cap indexes. These are DHR, UPS, NVDA, MSFT, TGT, TMO, DE, FDX.
WASHINGTON, Nov. 24, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCO...
Danaher (DHR) reported earnings 30 days ago. What's next for the stock?
Analyzing the investment case for one of the big winners from the coronavirus pandemic.
WASHINGTON, Nov. 16, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Wolfe Rese...
In this article we present the list of Top 10 Stocks Billionaire Ray Dalio Just Bought. Click to skip ahead and see the Top 5 Stocks Billionaire Ray Dalio Just Bought .
Danaher (DHR) to benefit from healthy growth opportunities in Life Sciences and Diagnostics segments, acquired assets and shareholders-friendly policies.
WASHINGTON, Nov. 10, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") today published its 2020 Sustainability Report, highlighting key environmental, social an...
The recent outperformances of these very different companies reveal much about which investment themes are working at this point in 2020.
The 2020s will see machine data become intelligence, intelligence become automation, and automation spread from factories to cities and your wrist. The post 7 5G Stocks to Buy for the Future o...
The company's diagnostic tests and life sciences research tools are being extensively used in the fight against the pandemic.
Danaher's last quarter earnings beat expected results on the bottom and top line and with a good gain over last year's results when the dividend was increased to 6%. Danaher's three-year forwa...
Investors focused on tech growth stocks may want to consider the following companies, as their quarterly revenue and net income have had strong growth on a year-over-year basis.
Richard Herman Driehaus created an investment approach using the buy high and sell higher theory.
DHR stock is at the heart of the Machine Internet, using sensors and networks to transform how other things are made. The post Buy Danaher Stock and Let It Work For You appeared first on Inves...
Top Ranked Momentum Stocks to Buy for October 23rd
Danaher Corp (NYSE: DHR) said on Thursday that its sales and profit in the fiscal third quarter came in better than expected. Shares of the company jumped more than 3% on market open.
Danaher Corporation (DHR) CEO Rainer Blair on Q3 2020 Results - Earnings Call Transcript
Danaher's (DHR) Q3 results reflect growth in Life Sciences and Diagnostics segments' sales, contribution from Cytiva, and operating margin rise. Core Q4 sales are likely to grow in high-single...
Danaher (DHR) delivered earnings and revenue surprises of 25.55% and 6.57%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Danaher (NYSE:DHR) fell 1% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 48.28% over the past year to $1.72, which beat ...
Danaher earnings beat third-quarter views, with Covid-19 tests fueling growth. DHR stock is trading at record highs.
WASHINGTON, Oct. 22, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended October 2, 2020. All results in this release reflect onl...
Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Five companies namely, Danaher (DHR), PulteGroup (PHM), Penske Automotive (PAG), Mattel (MAT) and Altra Industrial Motion (AIMC) with a favorable Zacks Rank are poised to beat earnings estimat...
Does Danaher (DHR) have what it takes to be a top stock pick for momentum investors? Let's find out.
These popular stocks have some of the best earnings charts of the week.
Danaher's (DHR) Q3 results are expected to reflect a healthy demand for products in Life Sciences and Diagnostics segments. Also, Cytiva is anticipated to have aided core sales.
The stock price of Danaher, a conglomerate with products in environmental, life sciences, and diagnostics fields, is up over 43% since the beginning of this year, significantly outperforming t...
Five corporate behemoths with a favorable Zacks Rank are poised to beat earnings estimates next week. Investment in these stocks will be fruitful at this stage.
Danaher (DHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stick to tried and tested Zacks methodology this earnings season for valuable pointers as significant uncertainties remain.
Danaher is a financial performance leader in healthcare equipment and diagnostics.
WASHINGTON, Oct. 7, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2020 on Thursday, Oct...
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
About DHR
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerosp... [Read more...]
Industry Diagnostics & Research | Founded 1969 |
CEO H. Lawrence Culp | Employees 60,000 |
Stock Exchange NYSE | Ticker Symbol DHR |
Financial Performance
In 2019, Danaher's revenue was $17.91 billion, an increase of 5.06% compared to the previous year's $17.05 billion. Earnings were $3.01 billion, an increase of 13.48%.
Analyst Forecasts
According to 21 analysts, the average rating for Danaher stock is "Buy." The 12-month stock price forecast is 265.47, which is an increase of 12.13% from the latest price.